Cargando…

Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia

BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction O...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Vaart, Thomas W, Prins, Jan M, Soetekouw, Robin, van Twillert, Gitte, Veenstra, Jan, Herpers, Bjorn L, Rozemeijer, Wouter, Jansen, Rogier R, Bonten, Marc J M, van der Meer, Jan T M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049276/
https://www.ncbi.nlm.nih.gov/pubmed/34272564
http://dx.doi.org/10.1093/cid/ciab632
_version_ 1784696109493387264
author van der Vaart, Thomas W
Prins, Jan M
Soetekouw, Robin
van Twillert, Gitte
Veenstra, Jan
Herpers, Bjorn L
Rozemeijer, Wouter
Jansen, Rogier R
Bonten, Marc J M
van der Meer, Jan T M
author_facet van der Vaart, Thomas W
Prins, Jan M
Soetekouw, Robin
van Twillert, Gitte
Veenstra, Jan
Herpers, Bjorn L
Rozemeijer, Wouter
Jansen, Rogier R
Bonten, Marc J M
van der Meer, Jan T M
author_sort van der Vaart, Thomas W
collection PubMed
description BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction Of Staphylococcus aureus Infective endocarditiseTime to positivity, Iv drug use, Vascular phenomena, preExisting heart condition (POSITIVE), Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT), and VIRSTA scores for classifying the likelihood of endocarditis in patients with SAB. METHODS: Between August 2017 and September 2019, we enrolled consecutive adult patients with SAB in a prospective cohort study in 7 hospitals in the Netherlands. Using the modified Duke Criteria for definite endocarditis as reference standard, sensitivity, specificity, negative predictive (NPV), and positive predictive values were determined for the POSITIVE, PREDICT, and VIRSTA scores. An NPV of at least 98% was considered safe for excluding endocarditis. RESULTS: Of 477 SAB patients enrolled, 33% had community-acquired SAB, 8% had a prosthetic valve, and 11% a cardiac implantable electronic device. Echocardiography was performed in 87% of patients, and 42% received transesophageal echocardiography (TEE). Eighty-seven (18.2%) had definite endocarditis. Sensitivity was 77.6% (65.8%–86.9%), 85.1% (75.8%–91.8%), and 98.9% (95.7%–100%) for the POSITIVE (n = 362), PREDICT, and VIRSTA scores, respectively. NPVs were 92.5% (87.9%–95.8%), 94.5% (90.7%–97.0%), and 99.3% (94.9%–100%). For the POSITIVE, PREDICT, and VIRSTA scores, 44.5%, 50.7%, and 70.9% of patients with SAB, respectively, were classified as at high risk for endocarditis. CONCLUSIONS: Only the VIRSTA score had an NPV of at least 98%, but at the expense of a high number of patients classified as high risk and thus requiring TEE. CLINICAL TRIALS REGISTRATION: Netherlands Trial Register code 6669.
format Online
Article
Text
id pubmed-9049276
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90492762022-04-29 Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia van der Vaart, Thomas W Prins, Jan M Soetekouw, Robin van Twillert, Gitte Veenstra, Jan Herpers, Bjorn L Rozemeijer, Wouter Jansen, Rogier R Bonten, Marc J M van der Meer, Jan T M Clin Infect Dis Major Articles and Commentaries BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction Of Staphylococcus aureus Infective endocarditiseTime to positivity, Iv drug use, Vascular phenomena, preExisting heart condition (POSITIVE), Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT), and VIRSTA scores for classifying the likelihood of endocarditis in patients with SAB. METHODS: Between August 2017 and September 2019, we enrolled consecutive adult patients with SAB in a prospective cohort study in 7 hospitals in the Netherlands. Using the modified Duke Criteria for definite endocarditis as reference standard, sensitivity, specificity, negative predictive (NPV), and positive predictive values were determined for the POSITIVE, PREDICT, and VIRSTA scores. An NPV of at least 98% was considered safe for excluding endocarditis. RESULTS: Of 477 SAB patients enrolled, 33% had community-acquired SAB, 8% had a prosthetic valve, and 11% a cardiac implantable electronic device. Echocardiography was performed in 87% of patients, and 42% received transesophageal echocardiography (TEE). Eighty-seven (18.2%) had definite endocarditis. Sensitivity was 77.6% (65.8%–86.9%), 85.1% (75.8%–91.8%), and 98.9% (95.7%–100%) for the POSITIVE (n = 362), PREDICT, and VIRSTA scores, respectively. NPVs were 92.5% (87.9%–95.8%), 94.5% (90.7%–97.0%), and 99.3% (94.9%–100%). For the POSITIVE, PREDICT, and VIRSTA scores, 44.5%, 50.7%, and 70.9% of patients with SAB, respectively, were classified as at high risk for endocarditis. CONCLUSIONS: Only the VIRSTA score had an NPV of at least 98%, but at the expense of a high number of patients classified as high risk and thus requiring TEE. CLINICAL TRIALS REGISTRATION: Netherlands Trial Register code 6669. Oxford University Press 2021-07-16 /pmc/articles/PMC9049276/ /pubmed/34272564 http://dx.doi.org/10.1093/cid/ciab632 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles and Commentaries
van der Vaart, Thomas W
Prins, Jan M
Soetekouw, Robin
van Twillert, Gitte
Veenstra, Jan
Herpers, Bjorn L
Rozemeijer, Wouter
Jansen, Rogier R
Bonten, Marc J M
van der Meer, Jan T M
Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
title Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
title_full Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
title_fullStr Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
title_full_unstemmed Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
title_short Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia
title_sort prediction rules for ruling out endocarditis in patients with staphylococcus aureus bacteremia
topic Major Articles and Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049276/
https://www.ncbi.nlm.nih.gov/pubmed/34272564
http://dx.doi.org/10.1093/cid/ciab632
work_keys_str_mv AT vandervaartthomasw predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT prinsjanm predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT soetekouwrobin predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT vantwillertgitte predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT veenstrajan predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT herpersbjornl predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT rozemeijerwouter predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT jansenrogierr predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT bontenmarcjm predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia
AT vandermeerjantm predictionrulesforrulingoutendocarditisinpatientswithstaphylococcusaureusbacteremia